Literature DB >> 17917462

Retrocollis: classification, clinical phenotype, treatment outcomes and risk factors.

Spiridon Papapetropoulos1, Sheila Baez, Jennifer Zitser, Cenk Sengun, Carlos Singer.   

Abstract

Retrocollis (RC) is a form of cervical dystonia (CD) that produces patterned, repetitive muscle contractions that result in neck extension. We performed a review of consecutive CD patients seen in our Division over a 15-year period. Out of 399 CD patients, 59 (14.8%) had features of RC. Pain was very frequently reported among patients ( approximately 80%). RC was frequently associated with neuroleptic exposure (20.3%) and a history of head/neck trauma (23.7%). Of patients injected with botulinum toxin type A, 24.5% reported excellent, 32.1% moderate, 16.9% mild and 24.5% no response to injections. Oral antidystonic medications had limited contribution to symptom relief. (c) 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917462     DOI: 10.1159/000109265

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  4 in total

1.  Predictable variables for short- and long-term botulinum toxin treatment response in patients with cervical dystonia.

Authors:  Andre C Felicio; Clecio Godeiro-Junior; Patricia de Carvalho Aguiar; Vanderci Borges; Sonia M A Silva; Henrique B Ferraz
Journal:  Neurol Sci       Date:  2009-05-26       Impact factor: 3.307

Review 2.  What's new in dystonia?

Authors:  Vicki Shanker; Susan B Bressman
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

3.  Dorsal midbrain syndrome associated with persistent neck extension: Clinical and diagnostic imaging findings in 2 dogs.

Authors:  Sara Canal; Massimo Baroni; Cristian Falzone; Giulia M De Benedictis; Marco Bernardini
Journal:  Can Vet J       Date:  2015-12       Impact factor: 1.008

4.  Retroform Cervical Dystonia: Target Muscle Selection and Efficacy of Botulinum Toxin Injection.

Authors:  Yaowen Hu; Lizhen Pan; Junhui Su; Shuzhen Chen; Xiaolong Zhang; Yougui Pan; Lingjing Jin; Fei Teng
Journal:  Front Neurol       Date:  2022-07-26       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.